1. Reinertson TE, Fortune JB, Peters JC, Pagnotta I, Balint JA. 1992; Primary leiomyoma of the liver. A case report and review of the literature. Dig Dis Sci. 37:622–627. DOI:
10.1007/BF01307591. PMID:
1551357.
2. Luo XZ, Ming CS, Chen XP, Gong NQ. 2013; Epstein-Barr virus negative primary hepatic leiomyoma: case report and literature review. World J Gastroenterol. 19:4094–4098. DOI:
10.3748/wjg.v19.i25.4094. PMID:
23840159. PMCID:
PMC3703201.
3. Demel R. 1926; Ein operierter Fall von Leber-Myom. Virchows Arch Pathol Anat Physiol Klin Med. 261:881–884. DOI:
10.1007/BF01892215.
4. Prévot S, Néris J, de Saint Maur PP. 1994; Detection of Epstein Barr virus in an hepatic leiomyomatous neoplasm in an adult human immunodeficiency virus 1-infected patient. Virchows Arch. 425:321–325. DOI:
10.1007/BF00196156. PMID:
7812519.
7. Santos I, Valls C, Leiva D, Serrano T, Martinez L, Ruiz S. 2011; Primary hepatic leiomyoma: case report. Abdom Imaging. 36:315–317. DOI:
10.1007/s00261-010-9648-y. PMID:
20959979.
8. Penn I. 1978; Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery. 83:492–502.
9. Lee ES, Locker J, Nalesnik M, et al. 1995; The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med. 332:19–25. DOI:
10.1056/NEJM199501053320104. PMID:
7990861.
10. Starzl TE, Nalesnik MA, Porter KA, et al. 1984; Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. 1:583–587. DOI:
10.1016/S0140-6736(84)90994-2. PMID:
6142304.
11. Jang SH, Kim SM, Sohn JS, Ryu KH, Yuk HB. 2016; A firm hepatic mass cannot be penetrated by US-guided needle biopsy. Clin Ultrasound. 1:126–129. DOI:
10.18525/cu.2016.1.2.126.